Trepo, Christian

Publishing since 1970 (Dinosaur)

Has published 539 publications in 41 years

Number of publications published per year by Trepo, Christian. (Source : PubMed)

Distribution of publications types for Trepo, Christian. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Trepo C, Bailly F. Maintenance ribavirin monotherapy: the case for post-transplantation recurrent hepatitis C.  Dig Liver Dis  2010;42;4  
•  Faurie P, Broussolle C, Zoulim F, Trepo C, Sève P. Sarcoidosis and hepatitis C: clinical description of 11 cases.  Eur J Gastroenterol Hepatol  2010  
•  Miailhes P, Pradat P, Chevallier M, Lacombe K, Bailly F, Cotte L, Trabaud MA, Boibieux A, Bottero J, Trepo C, Zoulim F. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.  J. Viral Hepat.  2010  
•  Lucifora J, Vincent IE, Berthillon P, Dupinay T, Michelet M, Protzer U, Zoulim F, Durantel D, Trepo C, Chemin I. Hepatitis B virus replication in primary macaque hepatocytes: Crossing the species barrier toward a new small primate model.  Hepatology  2010  
•  Pradat P, Trepo E, Potthoff A, Bakshi R, Young B, Trepo C, Lagier R, Moreno C, Lemmers A, Gustot T, Degre D, Adler M, Wedemeyer H. The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.  Hepatology  2010;51;1  
•  Merle P, Mornex F, Trepo C. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy.  Cancer Lett.  2009;286;1  
•  Ndongo N, Rechoum Y, De Sequeira S, Zoulim F, Trépo C, Drouet E, Petit MA. Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.  J. Med. Virol.  2009;81;10  
•  Trepo C, Pradat P. Hepatitis C: CIFN for re-treatment of PEG-IFN plus RBV nonresponders?  Nat Rev Gastroenterol Hepatol  2009;6;10  
•  Chemin I, Guillaud O, Queyron PC, Trépo C. Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection.  J. Hepatol.  2009;51;4  
•  Trépo C, Zoulim F. [Treatment of hepatitis B: new perspectives]  Gastroenterol. Clin. Biol.  2009;33;8-9  

[ See timeline ] [ See all publications ]